Global mRNA Drug Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global mRNA Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
By Company
- Moderna
- Pfizer
- Zydus Cadila
- Fosun Pharma
- CureVAC
- Sri Lankan Microorganisms
- BioNtech
- AstraZeneca
- Janssen
- Preventive Vaccines
- Therapeutic Vaccine
- Therapeutic Drugs
- Hospital
- Clinic
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 MRNA DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of mRNA Drug
1.2 mRNA Drug Segment by Type
1.2.1 Global mRNA Drug Market Value Comparison by Type (2023-2029)
1.2.2 Preventive Vaccines
1.2.3 Therapeutic Vaccine
1.2.4 Therapeutic Drugs
1.3 mRNA Drug Segment by Application
1.3.1 Global mRNA Drug Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global mRNA Drug Market Size Estimates and Forecasts
1.4.1 Global mRNA Drug Revenue 2018-2029
1.4.2 Global mRNA Drug Sales 2018-2029
1.4.3 Global mRNA Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 MRNA DRUG MARKET COMPETITION BY MANUFACTURERS
2.1 Global mRNA Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global mRNA Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global mRNA Drug Average Price by Manufacturers (2018-2023)
2.4 Global mRNA Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Drug, Product Type & Application
2.7 mRNA Drug Market Competitive Situation and Trends
2.7.1 mRNA Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest mRNA Drug Players Market Share by Revenue
2.7.3 Global mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 MRNA DRUG RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global mRNA Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global mRNA Drug Global mRNA Drug Sales by Region: 2018-2029
3.2.1 Global mRNA Drug Sales by Region: 2018-2023
3.2.2 Global mRNA Drug Sales by Region: 2024-2029
3.3 Global mRNA Drug Global mRNA Drug Revenue by Region: 2018-2029
3.3.1 Global mRNA Drug Revenue by Region: 2018-2023
3.3.2 Global mRNA Drug Revenue by Region: 2024-2029
3.4 North America mRNA Drug Market Facts & Figures by Country
3.4.1 North America mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America mRNA Drug Sales by Country (2018-2029)
3.4.3 North America mRNA Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Drug Market Facts & Figures by Country
3.5.1 Europe mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe mRNA Drug Sales by Country (2018-2029)
3.5.3 Europe mRNA Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Drug Market Facts & Figures by Country
3.6.1 Asia Pacific mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific mRNA Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific mRNA Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Drug Market Facts & Figures by Country
3.7.1 Latin America mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America mRNA Drug Sales by Country (2018-2029)
3.7.3 Latin America mRNA Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa mRNA Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa mRNA Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa mRNA Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global mRNA Drug Sales by Type (2018-2029)
4.1.1 Global mRNA Drug Sales by Type (2018-2023)
4.1.2 Global mRNA Drug Sales by Type (2024-2029)
4.1.3 Global mRNA Drug Sales Market Share by Type (2018-2029)
4.2 Global mRNA Drug Revenue by Type (2018-2029)
4.2.1 Global mRNA Drug Revenue by Type (2018-2023)
4.2.2 Global mRNA Drug Revenue by Type (2024-2029)
4.2.3 Global mRNA Drug Revenue Market Share by Type (2018-2029)
4.3 Global mRNA Drug Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global mRNA Drug Sales by Application (2018-2029)
5.1.1 Global mRNA Drug Sales by Application (2018-2023)
5.1.2 Global mRNA Drug Sales by Application (2024-2029)
5.1.3 Global mRNA Drug Sales Market Share by Application (2018-2029)
5.2 Global mRNA Drug Revenue by Application (2018-2029)
5.2.1 Global mRNA Drug Revenue by Application (2018-2023)
5.2.2 Global mRNA Drug Revenue by Application (2024-2029)
5.2.3 Global mRNA Drug Revenue Market Share by Application (2018-2029)
5.3 Global mRNA Drug Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Moderna mRNA Drug Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer mRNA Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Zydus Cadila
6.3.1 Zydus Cadila Corporation Information
6.3.2 Zydus Cadila Description and Business Overview
6.3.3 Zydus Cadila mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zydus Cadila mRNA Drug Product Portfolio
6.3.5 Zydus Cadila Recent Developments/Updates
6.4 Fosun Pharma
6.4.1 Fosun Pharma Corporation Information
6.4.2 Fosun Pharma Description and Business Overview
6.4.3 Fosun Pharma mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fosun Pharma mRNA Drug Product Portfolio
6.4.5 Fosun Pharma Recent Developments/Updates
6.5 CureVAC
6.5.1 CureVAC Corporation Information
6.5.2 CureVAC Description and Business Overview
6.5.3 CureVAC mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CureVAC mRNA Drug Product Portfolio
6.5.5 CureVAC Recent Developments/Updates
6.6 Sri Lankan Microorganisms
6.6.1 Sri Lankan Microorganisms Corporation Information
6.6.2 Sri Lankan Microorganisms Description and Business Overview
6.6.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sri Lankan Microorganisms mRNA Drug Product Portfolio
6.6.5 Sri Lankan Microorganisms Recent Developments/Updates
6.7 BioNtech
6.6.1 BioNtech Corporation Information
6.6.2 BioNtech Description and Business Overview
6.6.3 BioNtech mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BioNtech mRNA Drug Product Portfolio
6.7.5 BioNtech Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca mRNA Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Janssen
6.9.1 Janssen Corporation Information
6.9.2 Janssen Description and Business Overview
6.9.3 Janssen mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Janssen mRNA Drug Product Portfolio
6.9.5 Janssen Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 mRNA Drug Industry Chain Analysis
7.2 mRNA Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Drug Production Mode & Process
7.4 mRNA Drug Sales and Marketing
7.4.1 mRNA Drug Sales Channels
7.4.2 mRNA Drug Distributors
7.5 mRNA Drug Customers
8 MRNA DRUG MARKET DYNAMICS
8.1 mRNA Drug Industry Trends
8.2 mRNA Drug Market Drivers
8.3 mRNA Drug Market Challenges
8.4 mRNA Drug Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of mRNA Drug
1.2 mRNA Drug Segment by Type
1.2.1 Global mRNA Drug Market Value Comparison by Type (2023-2029)
1.2.2 Preventive Vaccines
1.2.3 Therapeutic Vaccine
1.2.4 Therapeutic Drugs
1.3 mRNA Drug Segment by Application
1.3.1 Global mRNA Drug Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global mRNA Drug Market Size Estimates and Forecasts
1.4.1 Global mRNA Drug Revenue 2018-2029
1.4.2 Global mRNA Drug Sales 2018-2029
1.4.3 Global mRNA Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 MRNA DRUG MARKET COMPETITION BY MANUFACTURERS
2.1 Global mRNA Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global mRNA Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global mRNA Drug Average Price by Manufacturers (2018-2023)
2.4 Global mRNA Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Drug, Product Type & Application
2.7 mRNA Drug Market Competitive Situation and Trends
2.7.1 mRNA Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest mRNA Drug Players Market Share by Revenue
2.7.3 Global mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 MRNA DRUG RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global mRNA Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global mRNA Drug Global mRNA Drug Sales by Region: 2018-2029
3.2.1 Global mRNA Drug Sales by Region: 2018-2023
3.2.2 Global mRNA Drug Sales by Region: 2024-2029
3.3 Global mRNA Drug Global mRNA Drug Revenue by Region: 2018-2029
3.3.1 Global mRNA Drug Revenue by Region: 2018-2023
3.3.2 Global mRNA Drug Revenue by Region: 2024-2029
3.4 North America mRNA Drug Market Facts & Figures by Country
3.4.1 North America mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America mRNA Drug Sales by Country (2018-2029)
3.4.3 North America mRNA Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Drug Market Facts & Figures by Country
3.5.1 Europe mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe mRNA Drug Sales by Country (2018-2029)
3.5.3 Europe mRNA Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Drug Market Facts & Figures by Country
3.6.1 Asia Pacific mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific mRNA Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific mRNA Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Drug Market Facts & Figures by Country
3.7.1 Latin America mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America mRNA Drug Sales by Country (2018-2029)
3.7.3 Latin America mRNA Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa mRNA Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa mRNA Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa mRNA Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global mRNA Drug Sales by Type (2018-2029)
4.1.1 Global mRNA Drug Sales by Type (2018-2023)
4.1.2 Global mRNA Drug Sales by Type (2024-2029)
4.1.3 Global mRNA Drug Sales Market Share by Type (2018-2029)
4.2 Global mRNA Drug Revenue by Type (2018-2029)
4.2.1 Global mRNA Drug Revenue by Type (2018-2023)
4.2.2 Global mRNA Drug Revenue by Type (2024-2029)
4.2.3 Global mRNA Drug Revenue Market Share by Type (2018-2029)
4.3 Global mRNA Drug Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global mRNA Drug Sales by Application (2018-2029)
5.1.1 Global mRNA Drug Sales by Application (2018-2023)
5.1.2 Global mRNA Drug Sales by Application (2024-2029)
5.1.3 Global mRNA Drug Sales Market Share by Application (2018-2029)
5.2 Global mRNA Drug Revenue by Application (2018-2029)
5.2.1 Global mRNA Drug Revenue by Application (2018-2023)
5.2.2 Global mRNA Drug Revenue by Application (2024-2029)
5.2.3 Global mRNA Drug Revenue Market Share by Application (2018-2029)
5.3 Global mRNA Drug Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Moderna mRNA Drug Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer mRNA Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Zydus Cadila
6.3.1 Zydus Cadila Corporation Information
6.3.2 Zydus Cadila Description and Business Overview
6.3.3 Zydus Cadila mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zydus Cadila mRNA Drug Product Portfolio
6.3.5 Zydus Cadila Recent Developments/Updates
6.4 Fosun Pharma
6.4.1 Fosun Pharma Corporation Information
6.4.2 Fosun Pharma Description and Business Overview
6.4.3 Fosun Pharma mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fosun Pharma mRNA Drug Product Portfolio
6.4.5 Fosun Pharma Recent Developments/Updates
6.5 CureVAC
6.5.1 CureVAC Corporation Information
6.5.2 CureVAC Description and Business Overview
6.5.3 CureVAC mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CureVAC mRNA Drug Product Portfolio
6.5.5 CureVAC Recent Developments/Updates
6.6 Sri Lankan Microorganisms
6.6.1 Sri Lankan Microorganisms Corporation Information
6.6.2 Sri Lankan Microorganisms Description and Business Overview
6.6.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sri Lankan Microorganisms mRNA Drug Product Portfolio
6.6.5 Sri Lankan Microorganisms Recent Developments/Updates
6.7 BioNtech
6.6.1 BioNtech Corporation Information
6.6.2 BioNtech Description and Business Overview
6.6.3 BioNtech mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BioNtech mRNA Drug Product Portfolio
6.7.5 BioNtech Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca mRNA Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Janssen
6.9.1 Janssen Corporation Information
6.9.2 Janssen Description and Business Overview
6.9.3 Janssen mRNA Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Janssen mRNA Drug Product Portfolio
6.9.5 Janssen Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 mRNA Drug Industry Chain Analysis
7.2 mRNA Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Drug Production Mode & Process
7.4 mRNA Drug Sales and Marketing
7.4.1 mRNA Drug Sales Channels
7.4.2 mRNA Drug Distributors
7.5 mRNA Drug Customers
8 MRNA DRUG MARKET DYNAMICS
8.1 mRNA Drug Industry Trends
8.2 mRNA Drug Market Drivers
8.3 mRNA Drug Market Challenges
8.4 mRNA Drug Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global mRNA Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global mRNA Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global mRNA Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global mRNA Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global mRNA Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global mRNA Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global mRNA Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market mRNA Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of mRNA Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of mRNA Drug, Product Type & Application
Table 12. Global Key Manufacturers of mRNA Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global mRNA Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global mRNA Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global mRNA Drug Sales Market Share by Region (2018-2023)
Table 19. Global mRNA Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global mRNA Drug Sales Market Share by Region (2024-2029)
Table 21. Global mRNA Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global mRNA Drug Revenue Market Share by Region (2018-2023)
Table 23. Global mRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global mRNA Drug Revenue Market Share by Region (2024-2029)
Table 25. North America mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific mRNA Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific mRNA Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific mRNA Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific mRNA Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific mRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global mRNA Drug Sales (K Units) by Type (2018-2023)
Table 51. Global mRNA Drug Sales (K Units) by Type (2024-2029)
Table 52. Global mRNA Drug Sales Market Share by Type (2018-2023)
Table 53. Global mRNA Drug Sales Market Share by Type (2024-2029)
Table 54. Global mRNA Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global mRNA Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global mRNA Drug Revenue Market Share by Type (2018-2023)
Table 57. Global mRNA Drug Revenue Market Share by Type (2024-2029)
Table 58. Global mRNA Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global mRNA Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global mRNA Drug Sales (K Units) by Application (2018-2023)
Table 61. Global mRNA Drug Sales (K Units) by Application (2024-2029)
Table 62. Global mRNA Drug Sales Market Share by Application (2018-2023)
Table 63. Global mRNA Drug Sales Market Share by Application (2024-2029)
Table 64. Global mRNA Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global mRNA Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global mRNA Drug Revenue Market Share by Application (2018-2023)
Table 67. Global mRNA Drug Revenue Market Share by Application (2024-2029)
Table 68. Global mRNA Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global mRNA Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Moderna Corporation Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Moderna mRNA Drug Product
Table 74. Moderna Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pfizer mRNA Drug Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Zydus Cadila Corporation Information
Table 81. Zydus Cadila Description and Business Overview
Table 82. Zydus Cadila mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Zydus Cadila mRNA Drug Product
Table 84. Zydus Cadila Recent Developments/Updates
Table 85. Fosun Pharma Corporation Information
Table 86. Fosun Pharma Description and Business Overview
Table 87. Fosun Pharma mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Fosun Pharma mRNA Drug Product
Table 89. Fosun Pharma Recent Developments/Updates
Table 90. CureVAC Corporation Information
Table 91. CureVAC Description and Business Overview
Table 92. CureVAC mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CureVAC mRNA Drug Product
Table 94. CureVAC Recent Developments/Updates
Table 95. Sri Lankan Microorganisms Corporation Information
Table 96. Sri Lankan Microorganisms Description and Business Overview
Table 97. Sri Lankan Microorganisms mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Sri Lankan Microorganisms mRNA Drug Product
Table 99. Sri Lankan Microorganisms Recent Developments/Updates
Table 100. BioNtech Corporation Information
Table 101. BioNtech Description and Business Overview
Table 102. BioNtech mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. BioNtech mRNA Drug Product
Table 104. BioNtech Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AstraZeneca mRNA Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Janssen Corporation Information
Table 111. Janssen Description and Business Overview
Table 112. Janssen mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Janssen mRNA Drug Product
Table 114. Janssen Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. mRNA Drug Distributors List
Table 118. mRNA Drug Customers List
Table 119. mRNA Drug Market Trends
Table 120. mRNA Drug Market Drivers
Table 121. mRNA Drug Market Challenges
Table 122. mRNA Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 1. Global mRNA Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global mRNA Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global mRNA Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global mRNA Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global mRNA Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global mRNA Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global mRNA Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market mRNA Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of mRNA Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of mRNA Drug, Product Type & Application
Table 12. Global Key Manufacturers of mRNA Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global mRNA Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global mRNA Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global mRNA Drug Sales Market Share by Region (2018-2023)
Table 19. Global mRNA Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global mRNA Drug Sales Market Share by Region (2024-2029)
Table 21. Global mRNA Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global mRNA Drug Revenue Market Share by Region (2018-2023)
Table 23. Global mRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global mRNA Drug Revenue Market Share by Region (2024-2029)
Table 25. North America mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific mRNA Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific mRNA Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific mRNA Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific mRNA Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific mRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global mRNA Drug Sales (K Units) by Type (2018-2023)
Table 51. Global mRNA Drug Sales (K Units) by Type (2024-2029)
Table 52. Global mRNA Drug Sales Market Share by Type (2018-2023)
Table 53. Global mRNA Drug Sales Market Share by Type (2024-2029)
Table 54. Global mRNA Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global mRNA Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global mRNA Drug Revenue Market Share by Type (2018-2023)
Table 57. Global mRNA Drug Revenue Market Share by Type (2024-2029)
Table 58. Global mRNA Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global mRNA Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global mRNA Drug Sales (K Units) by Application (2018-2023)
Table 61. Global mRNA Drug Sales (K Units) by Application (2024-2029)
Table 62. Global mRNA Drug Sales Market Share by Application (2018-2023)
Table 63. Global mRNA Drug Sales Market Share by Application (2024-2029)
Table 64. Global mRNA Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global mRNA Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global mRNA Drug Revenue Market Share by Application (2018-2023)
Table 67. Global mRNA Drug Revenue Market Share by Application (2024-2029)
Table 68. Global mRNA Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global mRNA Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Moderna Corporation Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Moderna mRNA Drug Product
Table 74. Moderna Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pfizer mRNA Drug Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Zydus Cadila Corporation Information
Table 81. Zydus Cadila Description and Business Overview
Table 82. Zydus Cadila mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Zydus Cadila mRNA Drug Product
Table 84. Zydus Cadila Recent Developments/Updates
Table 85. Fosun Pharma Corporation Information
Table 86. Fosun Pharma Description and Business Overview
Table 87. Fosun Pharma mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Fosun Pharma mRNA Drug Product
Table 89. Fosun Pharma Recent Developments/Updates
Table 90. CureVAC Corporation Information
Table 91. CureVAC Description and Business Overview
Table 92. CureVAC mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CureVAC mRNA Drug Product
Table 94. CureVAC Recent Developments/Updates
Table 95. Sri Lankan Microorganisms Corporation Information
Table 96. Sri Lankan Microorganisms Description and Business Overview
Table 97. Sri Lankan Microorganisms mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Sri Lankan Microorganisms mRNA Drug Product
Table 99. Sri Lankan Microorganisms Recent Developments/Updates
Table 100. BioNtech Corporation Information
Table 101. BioNtech Description and Business Overview
Table 102. BioNtech mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. BioNtech mRNA Drug Product
Table 104. BioNtech Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AstraZeneca mRNA Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Janssen Corporation Information
Table 111. Janssen Description and Business Overview
Table 112. Janssen mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Janssen mRNA Drug Product
Table 114. Janssen Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. mRNA Drug Distributors List
Table 118. mRNA Drug Customers List
Table 119. mRNA Drug Market Trends
Table 120. mRNA Drug Market Drivers
Table 121. mRNA Drug Market Challenges
Table 122. mRNA Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of mRNA Drug
Figure 2. Global mRNA Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global mRNA Drug Market Share by Type in 2022 & 2029
Figure 4. Preventive Vaccines Product Picture
Figure 5. Therapeutic Vaccine Product Picture
Figure 6. Therapeutic Drugs Product Picture
Figure 7. Global mRNA Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global mRNA Drug Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global mRNA Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global mRNA Drug Market Size (2018-2029) & (US$ Million)
Figure 13. Global mRNA Drug Sales (2018-2029) & (K Units)
Figure 14. Global mRNA Drug Average Price (US$/Unit) & (2018-2029)
Figure 15. mRNA Drug Report Years Considered
Figure 16. mRNA Drug Sales Share by Manufacturers in 2022
Figure 17. Global mRNA Drug Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest mRNA Drug Players: Market Share by Revenue in 2022
Figure 19. mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global mRNA Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America mRNA Drug Sales Market Share by Country (2018-2029)
Figure 22. North America mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 23. United States mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe mRNA Drug Sales Market Share by Country (2018-2029)
Figure 26. Europe mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 27. Germany mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific mRNA Drug Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific mRNA Drug Revenue Market Share by Region (2018-2029)
Figure 34. China mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America mRNA Drug Sales Market Share by Country (2018-2029)
Figure 42. Latin America mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 43. Mexico mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa mRNA Drug Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 49. Turkey mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of mRNA Drug by Type (2018-2029)
Figure 53. Global Revenue Market Share of mRNA Drug by Type (2018-2029)
Figure 54. Global mRNA Drug Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of mRNA Drug by Application (2018-2029)
Figure 56. Global Revenue Market Share of mRNA Drug by Application (2018-2029)
Figure 57. Global mRNA Drug Price (US$/Unit) by Application (2018-2029)
Figure 58. mRNA Drug Value Chain
Figure 59. mRNA Drug Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of mRNA Drug
Figure 2. Global mRNA Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global mRNA Drug Market Share by Type in 2022 & 2029
Figure 4. Preventive Vaccines Product Picture
Figure 5. Therapeutic Vaccine Product Picture
Figure 6. Therapeutic Drugs Product Picture
Figure 7. Global mRNA Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global mRNA Drug Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global mRNA Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global mRNA Drug Market Size (2018-2029) & (US$ Million)
Figure 13. Global mRNA Drug Sales (2018-2029) & (K Units)
Figure 14. Global mRNA Drug Average Price (US$/Unit) & (2018-2029)
Figure 15. mRNA Drug Report Years Considered
Figure 16. mRNA Drug Sales Share by Manufacturers in 2022
Figure 17. Global mRNA Drug Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest mRNA Drug Players: Market Share by Revenue in 2022
Figure 19. mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global mRNA Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America mRNA Drug Sales Market Share by Country (2018-2029)
Figure 22. North America mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 23. United States mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe mRNA Drug Sales Market Share by Country (2018-2029)
Figure 26. Europe mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 27. Germany mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific mRNA Drug Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific mRNA Drug Revenue Market Share by Region (2018-2029)
Figure 34. China mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America mRNA Drug Sales Market Share by Country (2018-2029)
Figure 42. Latin America mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 43. Mexico mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa mRNA Drug Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 49. Turkey mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of mRNA Drug by Type (2018-2029)
Figure 53. Global Revenue Market Share of mRNA Drug by Type (2018-2029)
Figure 54. Global mRNA Drug Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of mRNA Drug by Application (2018-2029)
Figure 56. Global Revenue Market Share of mRNA Drug by Application (2018-2029)
Figure 57. Global mRNA Drug Price (US$/Unit) by Application (2018-2029)
Figure 58. mRNA Drug Value Chain
Figure 59. mRNA Drug Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
